Price Alert

Elanco Animal Health (ELAN)

NYSE: ELAN · Real-Time Price · USD

17.99

0.18 (1.01%)

At close: Aug 14, 2025, 3:59 PM

17.99

0.00%

After-hours: Aug 14, 2025, 07:32 PM EDT

1.01% (1D)

Bid	17.45
Market Cap	8.94B
Revenue (ttm)	4.48B
Net Income (ttm)	434M
EPS (ttm)	0.88
PE Ratio (ttm)	20.44
Forward PE	17.47
Analyst	Buy

Ask	18
Volume	3,699,466
Avg. Volume (20D)	5,602,051
Open	17.57
Previous Close	17.81
Day's Range	17.39 - 18.00
52-Week Range	8.02 - 18.00
Beta	1.66

About ELAN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ELAN

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ELAN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Elanco Animal Health has released their quartely earnings on Aug 7, 2025:

Revenue of $1.24B exceeds estimates by $52.13M, with 21.67% YoY growth.

EPS of 0.26 exceeds estimates by 0.06, with -13.33% YoY decline.

Next Earnings Release

Elanco Animal Health is scheduled to release its earnings on Nov 6, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

+17.8%

Elanco Animal Health shares are trading higher aft... Unlock content with Pro Subscription

3 months ago

+26.29%

Elanco Animal Health shares arre trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 revenue guidance above estimates. Also, the company issued FY25 adjusted EPS guidance with its midpoint above estimates.

News

1 week ago · seekingalpha.com

Elanco Animal Health Incorporated (ELAN) Q2 2025 Earnings Call Transcript

Elanco Animal Health Incorporated (NYSE:ELAN ) Q2 2025 Earnings Conference Call August 7, 2025 9:00 AM ET Company Participants Jeffrey N. Simmons - President, CEO & Director Robert M.

1 week ago · seekingalpha.com

Elanco Animal Health Q2: Rising Innovation Revenue, Initiate At Buy

I rate Elanco Animal Health Incorporated shares a Buy with a $20 fair value, driven by strong innovation and recent operational improvements. Elanco's focus on innovative products like Zenrelia and st...

1 week ago · benzinga.com

Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook

Elanco Animal Health Incorporated ELAN reported second-quarter 2025 results on Thursday, posting adjusted earnings per share of 26 cents, down 13% year over year.

1 week ago · zacks.com

Elanco Animal Health (ELAN) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Elanco Animal Health (ELAN) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with ...

1 week ago · zacks.com

Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates

Elanco Animal Health Incorporated (ELAN) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.3 per share a year...

1 week ago · zacks.com

Curious about Elanco Animal Health (ELAN) Q2 Performance? Explore Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Elanco Animal Health (ELAN), delve into some of its key metrics to gain a deeper insight into the company's potential performanc...

3 weeks ago · zacks.com

ELAN vs. USPH: Which Stock Is the Better Value Option?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Elanco Animal Health Incorporated (ELAN) and U.S. Physical Therapy (USPH). But which of these two stock...

1 month ago · reuters.com

Elanco's dog flu vaccine gets USDA nod

Elanco Animal Health said on Wednesday the U.S. Department of Agriculture (USDA) has approved its canine flu vaccine, which offers dogs protection against serious respiratory disease.

1 month ago · benzinga.com

Elanco Animal Health Gets Its Bite Back, Pipeline Efforts Earn Praise

After years of struggling with market share losses and uneven execution, Elanco Animal Health Incorporated ELAN appears to be turning a corner.

2 months ago · zacks.com

What Makes Elanco Animal Health (ELAN) a New Buy Stock

Elanco Animal Health (ELAN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Load More News